Nourish raises $100M for virtual nutrition carenews2026-05-19T12:00:10+00:00May 19th, 2026|Endpoints News|
Relay’s PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies studynews2026-05-19T11:13:43+00:00May 19th, 2026|Endpoints News|
BioMarin’s rare disease therapy shows no clinical benefit in Phase 3 testnews2026-05-19T10:18:01+00:00May 19th, 2026|Endpoints News|
Amgen stands by rare disease drug Tavneos amid Japan liver toxicity reportnews2026-05-18T18:21:35+00:00May 18th, 2026|Endpoints News|
FDA’s unreleased Covid vaccine deaths report is published by lawmakernews2026-05-18T17:52:59+00:00May 18th, 2026|Endpoints News|
Regeneron reaches $125M Parabilis deal for hard-to-catch drug targetsnews2026-05-18T15:33:27+00:00May 18th, 2026|Endpoints News|
Design Therapeutics’ Friedreich’s ataxia data; Vincentage’s obesity results from Chinanews2026-05-18T14:56:46+00:00May 18th, 2026|Endpoints News|
Merck’s ADC sac-TMT gets its first global Phase 3 win ahead of schedulenews2026-05-18T14:44:01+00:00May 18th, 2026|Endpoints News|
The Supreme Court won’t take up drugmakers’ IRA casesnews2026-05-18T14:32:27+00:00May 18th, 2026|Endpoints News|
Regeneron’s Phase 3 skin cancer miss adds to mounting failures in LAG-3news2026-05-18T10:34:21+00:00May 18th, 2026|Endpoints News|
